Results 101 to 110 of about 16,071 (223)
Ubiquitin-independent pathway regulates the RIT1-MAPK pathway in chordoma progression
Chordoma is a rare, slow-growing malignant tumor originating from embryonic notochord remnants and is often found in the sacrum or skull base. It is categorized into conventional, poorly differentiated, and dedifferentiated types, with the conventional ...
Hui Chen +10 more
doaj +1 more source
Background: Chordoma is a rare malignant neoplasm that predominantly arises from the axial skeleton, but can also develop in unusual locations. However, there are also rare cases of „NOS“ chordoma involving the oropharyx and epithelial-myoepithelial carcinoma of the parotid gland in the same patient.
Ramas, Almedina +4 more
openaire +2 more sources
Defective homologous recombination DNA repair as therapeutic target in advanced chordoma
Chordomas are rare bone tumors with few therapeutic options. Here we show, using whole-exome and genome sequencing within a precision oncology program, that advanced chordomas (n = 11) may be characterized by genomic patterns indicative of defective ...
S. Gröschel +38 more
semanticscholar +1 more source
A zebrafish model of chordoma initiated by notochord-driven expression of HRASV12
Chordoma is a malignant tumor thought to arise from remnants of the embryonic notochord, with its origin in the bones of the axial skeleton. Surgical resection is the standard treatment, usually in combination with radiation therapy, but neither ...
Alexa Burger +7 more
doaj +1 more source
Objective To investigate the clinical and pathological characteristics of sellar chondroid chordoma and discuss differential diagnosis of sellar chondroid chordoma with literature review.
Xia LI +4 more
doaj
SIRT5 promote malignant advancement of chordoma by regulating the desuccinylation of c-myc
Chordoma is a relatively rare and locally aggressive malignant tumor. Sirtuin (SIRT)5 plays pivotal roles in various tumors, but the role of SIRT5 in chordoma has not been found.
Minghui Jiang +5 more
doaj +1 more source

